Noteworthy findings over the past year have included the growing importance of nephron-sparing surgery, a promising new drug for metastatic renal cell carcinoma (RCC) and a nomogram to assist treatment decision making in elderly patients—all important principles in the treatment of RCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bensalah, K., Crépel, M. & Patard, J. J. Tumor size and nephron-sparing surgery: does it still matter? Eur. Urol. 53, 691–693 (2008).
Weight, C. J. et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J. Urol. 183, 1317–1323 (2010).
Thompson, R. H. et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur. Urol. 58, 340–345 (2010).
Bensalah, K. et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur. Urol. 57, 466–471 (2010).
Yossepowitch, O. et al. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J. Urol. 179, 2158–2163 (2008).
Sternberg, C. N. et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J. Clin. Oncol. 28, 1061–1068 (2010).
Chawla, S. N. et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J. Urol. 175, 425–431 (2006).
Kutikov, A., Egleston, B. L., Wong, Y. N. & Uzzo, R. G. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J. Clin. Oncol. 28, 311–317 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bensalah, K., Patard, JJ. Drugs, surgery and survival in RCC. Nat Rev Urol 8, 66–68 (2011). https://doi.org/10.1038/nrurol.2010.228
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2010.228
This article is cited by
-
CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities
Clinical and Translational Oncology (2014)
